Janssen is a pharmaceutical company focused on developing innovative medicines to improve patient health. They focus on areas such as neuroscience, immunology, infectious diseases, oncology, and cardiovascular and metabolic diseases.
- Founded in 1953 by Dr. Paul Janssen in Belgium
- Acquired by Johnson & Johnson in 1961
- Has since expanded globally, with operations in over 60 countries
- Has brought to market over 40 major treatments, including Remicade, Prezista, and Stelara
Pfizer is an American pharmaceutical company that produces vaccines, oncology drugs, and other medications.
Novartis is a Swiss multinational pharmaceutical company known for producing treatments in multiple therapeutic areas, including oncology, immunology, and neuroscience.
Roche is a Swiss multinational healthcare company that develops diagnostics and pharmaceuticals in oncology, immunology, and other areas.
Used for the treatment of autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and other conditions
Used for the treatment of HIV-1 infection in combination with other antiretroviral agents
Used for the treatment of psoriasis, psoriatic arthritis, and Crohn's disease
Janssen is known for its treatments in areas such as neuroscience, immunology, infectious diseases, oncology, and cardiovascular and metabolic diseases.
Janssen has developed over 40 major treatments, including Remicade, Prezista, and Stelara, which are used to treat autoimmune diseases, HIV, and conditions such as psoriasis and Crohn's disease.
Yes, Janssen is a subsidiary of Johnson & Johnson.
Yes, Janssen has operations in over 60 countries worldwide.
Competitors of Janssen include pharmaceutical companies such as Pfizer, Novartis, and Roche, which produce drugs in similar therapeutic areas such as oncology, immunology, and infectious diseases.